Book Melanoma Genetic Risk Test | Lahalak Medical Platform

A precision genetic test identifying hereditary mutations linked to cutaneous melanoma. Ideal for families with a history of skin cancer to enable early detection and personalized preventive care strategies.

Scientific name: Melanoma Genetic Risk Assessment (CDKN2A/CDK4)

An advanced laboratory test screening for CDKN2A and CDK4 mutations associated with hereditary melanoma. It assesses genetic predisposition, helping clinicians develop personalized surveillance and preventive monitoring plans.

Melanoma Genetic Risk Assessment (CDKN2A/CDK4) - Secure Your Family's Skin Health
Service type Genetic Laboratory Test
Duration 15-20 minutes
Fasting Fasting is not required

Included Services

  • Blood sample or buccal swab collection
  • CDKN2A and CDK4 gene sequencing
  • Comprehensive genetic report

Medical Service Information

Why perform this test?

  • To identify genetic predisposition to melanoma.
  • To assess clinical risks for first-degree relatives.
  • To establish personalized screening and prevention plans.

Who should get tested?

  • Individuals with two or more family members diagnosed with melanoma.
  • Patients diagnosed with melanoma at a young age.
  • Families with a combined history of melanoma and pancreatic cancer.

Preparation & Requirements

  • No fasting is required for this genetic assessment.
  • A consultation with a genetic counselor is highly recommended.
  • Provide detailed family history to the laboratory if possible.

Conditions & Notices

  • Detailed family medical history is recommended

Medical services you might also like